sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
PRQR
Updated 10/6/2026, 10:27 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| PRQR ProQR Therapeutics N.V. | Buy | $353,960 | de Boer Daniel Anton Chief Executive Officer, Director | 200,000 sh | at $1.77 | Filed Aug 3, 4:01 PM ET | Filing | |
| PRQR ProQR Therapeutics N.V. | Buy | $257,925 | Filius Bart Director | 150,000 sh | at $1.72 | Filed Jul 21, 8:00 AM ET | Filing | |
| PRQR ProQR Therapeutics N.V. | Buy | $261,000 | de Boer Daniel Anton Chief Executive Officer, Director | 150,000 sh | at $1.74 | Filed Jul 13, 8:00 AM ET | Filing | |
| PRQR ProQR Therapeutics N.V. | Buy | $238,500 | de Boer Daniel Anton Chief Executive Officer, Director | 150,000 sh | at $1.59 | Filed Jul 8, 2:55 PM ET | Filing |